Development of Anti-Atherosclerosis Therapy Based on the Inflammatory and Proliferative Aspects of the Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|9|1196-1204

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.9, 2015-03, pp. : 1196-1204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of microRNAs as Anti-Atherosclerosis

By  

Mini Reviews in Medicinal Chemistry, Vol. 15, Iss. 6, 2015-05 ,pp. : 452-458

Bentham Science Publishers

Access to resources Recommend Favorite

Novel anti-inflammatory therapy for Parkinson's disease

By Gao H.-M.   Liu B.   Zhang W.   Hong J.-S.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 8, 2003-08 ,pp. : 395-401

Elsevier

Access to resources Recommend Favorite

Anti-Inflammatory Gene Therapy for Cardiovascular Disease

By  

Current Gene Therapy, Vol. 11, Iss. 6, 2011-12 ,pp. : 442-446

Bentham Science Publishers

Access to resources Recommend Favorite

Atherosclerosis as an Inflammatory Disease

By  

Current Pharmaceutical Design, Vol. 18, Iss. 28, 2012-09 ,pp. : 4266-4288

Bentham Science Publishers

Access to resources Recommend Favorite

The Effect of Anti-B-cell Therapy on the Development of Atherosclerosis in Patients with Rheumatoid Arthritis

By  

Current Pharmaceutical Design, Vol. 18, Iss. 11, 2012-04 ,pp. : 1512-1518

Bentham Science Publishers

Access to resources Recommend Favorite